Diagnosis and treatment of migraine

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Despite recent advances in understanding the pathophysiology and treatment of migraine, considerable uncertainty remains surrounding the diagnosis and treatment of this disorder. This uncertainty is reflected in studies that show both underdiagnosis and undertreatment of migraine. While the diagnosis can be assisted by criteria from the International Headache Society, other approaches may be useful in clinical practice. Treatment of migraine must be based on an individualized patient strategy that integrates education, patient participation, and effective use of pharmacological interventions. Many patients, despite self-treatment with simple analgesics, continue to suffer considerable disability associated with their migraines. Triptans, which are more effective at relieving migraine symptoms and maintaining patient function than are non-specific therapies, are used in only a minority of patients with migraine. Treatment goals of rapid, complete relief with no recurrence and minimal adverse effects can be achieved when effective therapy is matched to individual patient goals. For prophylaxis, anticonvulsant drugs emerging as effective options are being added to the armamentarium with traditional compounds such as tricyclic antidepressants and β-blockers.

Original languageEnglish (US)
Pages (from-to)255-261
Number of pages7
JournalMayo Clinic Proceedings
Volume77
Issue number3
StatePublished - 2002

Fingerprint

Migraine Disorders
Therapeutics
Uncertainty
Tryptamines
Patient Participation
Tricyclic Antidepressive Agents
Patient Education
Anticonvulsants
Headache
Analgesics
Pharmacology
Recurrence

Keywords

  • IHS = International Headache Society
  • NSAID = Nonsteroidal anti-inflammatory drug

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Diagnosis and treatment of migraine. / Cady, Roger; Dodick, David William.

In: Mayo Clinic Proceedings, Vol. 77, No. 3, 2002, p. 255-261.

Research output: Contribution to journalArticle

Cady, R & Dodick, DW 2002, 'Diagnosis and treatment of migraine', Mayo Clinic Proceedings, vol. 77, no. 3, pp. 255-261.
Cady, Roger ; Dodick, David William. / Diagnosis and treatment of migraine. In: Mayo Clinic Proceedings. 2002 ; Vol. 77, No. 3. pp. 255-261.
@article{c7cddc56edb24a10882efd8c56afe1f5,
title = "Diagnosis and treatment of migraine",
abstract = "Despite recent advances in understanding the pathophysiology and treatment of migraine, considerable uncertainty remains surrounding the diagnosis and treatment of this disorder. This uncertainty is reflected in studies that show both underdiagnosis and undertreatment of migraine. While the diagnosis can be assisted by criteria from the International Headache Society, other approaches may be useful in clinical practice. Treatment of migraine must be based on an individualized patient strategy that integrates education, patient participation, and effective use of pharmacological interventions. Many patients, despite self-treatment with simple analgesics, continue to suffer considerable disability associated with their migraines. Triptans, which are more effective at relieving migraine symptoms and maintaining patient function than are non-specific therapies, are used in only a minority of patients with migraine. Treatment goals of rapid, complete relief with no recurrence and minimal adverse effects can be achieved when effective therapy is matched to individual patient goals. For prophylaxis, anticonvulsant drugs emerging as effective options are being added to the armamentarium with traditional compounds such as tricyclic antidepressants and β-blockers.",
keywords = "IHS = International Headache Society, NSAID = Nonsteroidal anti-inflammatory drug",
author = "Roger Cady and Dodick, {David William}",
year = "2002",
language = "English (US)",
volume = "77",
pages = "255--261",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "3",

}

TY - JOUR

T1 - Diagnosis and treatment of migraine

AU - Cady, Roger

AU - Dodick, David William

PY - 2002

Y1 - 2002

N2 - Despite recent advances in understanding the pathophysiology and treatment of migraine, considerable uncertainty remains surrounding the diagnosis and treatment of this disorder. This uncertainty is reflected in studies that show both underdiagnosis and undertreatment of migraine. While the diagnosis can be assisted by criteria from the International Headache Society, other approaches may be useful in clinical practice. Treatment of migraine must be based on an individualized patient strategy that integrates education, patient participation, and effective use of pharmacological interventions. Many patients, despite self-treatment with simple analgesics, continue to suffer considerable disability associated with their migraines. Triptans, which are more effective at relieving migraine symptoms and maintaining patient function than are non-specific therapies, are used in only a minority of patients with migraine. Treatment goals of rapid, complete relief with no recurrence and minimal adverse effects can be achieved when effective therapy is matched to individual patient goals. For prophylaxis, anticonvulsant drugs emerging as effective options are being added to the armamentarium with traditional compounds such as tricyclic antidepressants and β-blockers.

AB - Despite recent advances in understanding the pathophysiology and treatment of migraine, considerable uncertainty remains surrounding the diagnosis and treatment of this disorder. This uncertainty is reflected in studies that show both underdiagnosis and undertreatment of migraine. While the diagnosis can be assisted by criteria from the International Headache Society, other approaches may be useful in clinical practice. Treatment of migraine must be based on an individualized patient strategy that integrates education, patient participation, and effective use of pharmacological interventions. Many patients, despite self-treatment with simple analgesics, continue to suffer considerable disability associated with their migraines. Triptans, which are more effective at relieving migraine symptoms and maintaining patient function than are non-specific therapies, are used in only a minority of patients with migraine. Treatment goals of rapid, complete relief with no recurrence and minimal adverse effects can be achieved when effective therapy is matched to individual patient goals. For prophylaxis, anticonvulsant drugs emerging as effective options are being added to the armamentarium with traditional compounds such as tricyclic antidepressants and β-blockers.

KW - IHS = International Headache Society

KW - NSAID = Nonsteroidal anti-inflammatory drug

UR - http://www.scopus.com/inward/record.url?scp=0036183608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036183608&partnerID=8YFLogxK

M3 - Article

C2 - 11888029

AN - SCOPUS:0036183608

VL - 77

SP - 255

EP - 261

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 3

ER -